Figure 5.
Mass cytometric analysis of TTEcells in MGUS and NDMM patients. (A) Biaxial contour plots gated for CD8+T cells show distribution of CD69+TTE and CD69−TTE cells in NDMM and MGUS patients. Regions occupied by CD69+TTE and CD69−TTE cells are indicated. Numbers indicate proportions of CD69+TTE and CD69−TTE cells within BM-CD8+T and PB-CD8+T cells of NDMM and MGUS patients. (B) tSNE plots show distribution of CD69−TTE and CD69+TTE cells within pooled BM-TTE and PB-TTE cells of NDMM patients (n = 5, shown in Figure 4A) and MGUS patients (n = 3). The area occupied by CD69+TTE cells is indicated by the red dotted circle. Bars (median with scatter plots) show proportions of CD69−TTE and CD69+TTE cells within TTE (C) and CD8+T (D) cells in the BM and PB of NDMM (n = 8) and MGUS (n = 4) patients. *P < .05. (E) Graph shows proportion of CD69+ cells within the TN, TM, and TTE compartments in the BM of MGUS (n = 4) and NDMM (n = 8) patients. TN, TM, and TTE cells from the same patient are connected by lines. ***P < .001; Friedman test with Dunn’s multiple comparators. (F) Heat map showing the phenotype of the 25 MCs defined by FlowSOM analysis of TTE cells. MC5, MC6, MC9, and MC11 contain CD69+TTE cells, and CD69−TTE cells are distributed within the remaining 21 MCs. The intensity of the color in each cell indicates the median signal intensity for an individual marker (row) in an individual MC (column). (G) Pie charts show the contribution of CD69+TTE cells assigned to MC5, MC6, MC9, and MC11 to the BM-TTE cells in NDMM (n = 5) and MGUS (n = 3) patients. Numbers indicate total CD69+TTE cells within MC5, MC6, MC9, and MC11 in each patient, expressed as a percentage of total BM-TTE cells.

Mass cytometric analysis of TTEcells in MGUS and NDMM patients. (A) Biaxial contour plots gated for CD8+T cells show distribution of CD69+TTE and CD69TTE cells in NDMM and MGUS patients. Regions occupied by CD69+TTE and CD69TTE cells are indicated. Numbers indicate proportions of CD69+TTE and CD69TTE cells within BM-CD8+T and PB-CD8+T cells of NDMM and MGUS patients. (B) tSNE plots show distribution of CD69TTE and CD69+TTE cells within pooled BM-TTE and PB-TTE cells of NDMM patients (n = 5, shown in Figure 4A) and MGUS patients (n = 3). The area occupied by CD69+TTE cells is indicated by the red dotted circle. Bars (median with scatter plots) show proportions of CD69TTE and CD69+TTE cells within TTE (C) and CD8+T (D) cells in the BM and PB of NDMM (n = 8) and MGUS (n = 4) patients. *P < .05. (E) Graph shows proportion of CD69+ cells within the TN, TM, and TTE compartments in the BM of MGUS (n = 4) and NDMM (n = 8) patients. TN, TM, and TTE cells from the same patient are connected by lines. ***P < .001; Friedman test with Dunn’s multiple comparators. (F) Heat map showing the phenotype of the 25 MCs defined by FlowSOM analysis of TTE cells. MC5, MC6, MC9, and MC11 contain CD69+TTE cells, and CD69TTE cells are distributed within the remaining 21 MCs. The intensity of the color in each cell indicates the median signal intensity for an individual marker (row) in an individual MC (column). (G) Pie charts show the contribution of CD69+TTE cells assigned to MC5, MC6, MC9, and MC11 to the BM-TTE cells in NDMM (n = 5) and MGUS (n = 3) patients. Numbers indicate total CD69+TTE cells within MC5, MC6, MC9, and MC11 in each patient, expressed as a percentage of total BM-TTE cells.

Close Modal

or Create an Account

Close Modal
Close Modal